Alpa Laboratories Ltd
Ticker: ALPA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
88.39
Market Cap
185.98
Debt/Equity
0.0002
ROE %
12.062
PB
1.0849
Promoter %
57.294
Pledge %
0.000
1Y Rev Growth %
9.844
5Y Rev Growth %
8.848
NP Margin %
14.359
NP Margin 5Y Avg %
11.759
Trading Reference
1M Return %
-5.462
6M Return %
-19.242
1Y Return %
-25.897
% Away 52W High
55.334
% Away 52W Low
1.086
Daily Volume
6726
Investment Verdict
Buy
Score 80/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Alpa Laboratories Ltd is currently trading near a key support level, with recent volume indicating strong buying interest. If the stock can break above the resistance level at 150, it could see a potential upside. However, if it falls below the support at 130, there could be significant downside risk.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
H
HB Estate Developers Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Dolfin Rubbers Ltd
Dolfin Rubbers Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Integra Essentia Ltd
Integra Essentia Ltd shows potential in a growing sector, but faces challenges in execution and market competition.
View details
A
Amba Enterprises Ltd
Amba Enterprises Ltd presents several risks with inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
B
BEW Engineering Ltd
BEW Engineering Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
M
Manaksia Aluminium Co Ltd
The stock shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
B
Barflex Polyfilms Ltd
Barflex Polyfilms Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
M
Maral Overseas Ltd
Maral Overseas Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
E
Enfuse Solutions Ltd
Enfuse Solutions Ltd shows potential but faces significant challenges in growth consistency and market valuation.
View details
E
Eyantra Ventures Ltd
Eyantra Ventures Ltd presents a decent investment opportunity, but caution is advised due to inconsistent growth and profitability metrics.
View details
T
Tainwala Chemicals and Plastics (India) Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
M
Modern Threads (India) Ltd
While Modern Threads operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.
View details
N
Natural Capsules Ltd
Natural Capsules Ltd shows potential for growth but faces challenges in profitability and execution risks.
View details
C
CHL Ltd
CHL Ltd shows some potential but faces challenges in growth and profitability metrics. Caution is advised.
View details
S
Star Housing Finance Ltd
Star Housing Finance Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment.
View details
S
Sonam Ltd
Sonam Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
Business Overview
Alpa Laboratories Ltd is a leading Indian pharmaceutical company dedicated to manufacturing high-quality generic and specialty medicines. With a strong focus on research and development, the company caters to diverse therapeutic segments, ensuring accessibility to essential healthcare solutions. Alpa Laboratories is committed to innovation and sustainability, making it a trusted partner for healthcare providers and patients alike. Its robust distribution network ensures that products reach those in need efficiently, enhancing overall health outcomes across the nation.
- Established leader in the Indian pharmaceutical sector
- Focus on high-quality generic and specialty medicines
- Strong commitment to research and development
- Extensive distribution network for efficient access
- Dedicated to innovation and sustainability
- Trusted partner for healthcare providers and patients
Investment Thesis
Alpa Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company well for sustainable growth and shareholder value enhancement.
- Strong promoter group with a proven track record enhances investor confidence.
- Robust growth potential in digital services aligns with market trends.
- Valuation metrics indicate Alpa is undervalued compared to industry peers.
- Strategic initiatives in R&D could drive future revenue streams.
- Resilient business model ensures stability in fluctuating market conditions.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D capabilities
- Strategic partnerships with hospitals
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Dependence on key suppliers
Peer Perspective
Alpa Laboratories Ltd trades at a discount to peers like Sun Pharma and Cipla, highlighting potential upside. A sustained improvement in margins and consistent growth could trigger a rerating in its valuation.
Future Outlook
Alpa Laboratories Ltd is well-positioned for growth, driven by innovation and market expansion. However, successful execution and stringent cost control will be crucial to fully realize its potential in the coming years.
AI FAQs for Retail Users
- Q: What does Alpa Laboratories Ltd do?A: Alpa Laboratories Ltd is involved in manufacturing pharmaceutical products and active pharmaceutical ingredients.
- Q: Is Alpa Laboratories Ltd a good investment?A: Investing depends on your financial goals and risk tolerance. Research the company and market conditions.
- Q: What are the recent developments in Alpa Laboratories Ltd?A: Check the latest news and company announcements for updates on products and performance.
- Q: How can I buy shares of Alpa Laboratories Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What risks are associated with investing in Alpa Laboratories Ltd?A: Like all stocks, risks include market volatility, regulatory changes, and company performance.
📊 Stock Investment Checklist (100 Points)
Alpa Laboratories Ltd • Updated: 2025-09-16 19:26:05
-
8BusinessHighPharmaceutical sector shows potential with ongoing demand.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
9ValuationHighP/E and P/B ratios are above industry average, indicating overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodLimited growth drivers identified, execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Alpa Laboratories Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside valuation concerns.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100